James Allison and Robert Schreiber won the Balzan Prize for their contributions to immunological approaches in cancer therapy. According to the prize committee, “Professors Schreiber and Allison have played transformative roles in the field of tumor immunology, Schreiber by demonstrating that the immune system is crucially involved in fighting tumours and by introducing the concept...
The Oncologic Drugs Advisory Committee held its first session since President Trump’s inauguration, with a two-day, back-to-back marathon meeting, signaling a return to business at FDA after significant upheaval at the agency.
